Atea Pharmaceuticals, Inc. AVIR
4.31 USD +0.09 (+2.13%)
At closeNov 6, 2026, 5:20 PM EST
4.39 +0.08 +1.86%
After hours · Nov 6, 5:20 PM ET
4.12 Day range 4.34
2.96 52-week range 6.15
- YTD
- +20.73%
- 1 year
- +32.62%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -180.89M | -192.95M | -164.16M | -130.65M | 138.38M | |
| -158.35M | -168.38M | -135.96M | -115.91M | 121.19M | |
| -1.94 | -2.00 | -1.63 | -1.39 | 1.37 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 95.71M | 64.70M | 143.82M | 188.66M | 764.68M | |
| 315.22M | 464.67M | 594.97M | 666.71M | 772.89M | |
| 39.78M | 25.80M | 39.78M | 26.14M | 62.81M | |
| 843.00K | 1.64M | 2.40M | 3.12M | 197.00K | |
| 275.43M | 438.87M | 555.19M | 640.57M | 710.08M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -132.03M | -135.50M | -85.39M | -120.98M | -87.00M | |
| 188.79M | 56.10M | 40.30M | -455.41M | -4.00K | |
| -25.75M | 267.00K | 257.00K | 370.00K | 1.47M | |
| 31.02M | -79.13M | -44.84M | -576.02M | -85.54M |